Metrikler
Yayın
20
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (15)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (14)
Scopus (15)
2014
20141. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer
Tural D., Selcukbiricik F., Yildiz O., Elcin O., Erdamar S., Guney S., et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
, cilt.19, sa.5, ss.889-896, 2014 (SCI-Expanded, Scopus)
2013
20132. Gastric cancer: A case study in Turkey
Tural D., Selcukbiricik F., Akar E., Serdengecti S., Buyukunal E.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.9, sa.4, ss.644-648, 2013 (SCI-Expanded, Scopus)
2013
20133. The Relation between Pathological Complete Response and Clinical Outcome in Patients with Rectal Cancer
Tural D., Selcukbiricik F., Ozturk M. A., Yildiz O., Turna H., Er-damar S., et al.
HEPATO-GASTROENTEROLOGY
, cilt.60, sa.126, ss.1365-1370, 2013 (SCI-Expanded, Scopus)
2013
20134. Male Breast Cancer: 37-Year Data Study at a Single Experience Center in Turkey
Selcukbiricik F., Tural D., Aydogan F., Bese N., Buyukunal E., Serdengecti S.
JOURNAL OF BREAST CANCER
, cilt.16, sa.1, ss.60-65, 2013 (SCI-Expanded, Scopus)
2013
20135. Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial
YALÇIN Ş., Uslu R., DANE F., Yilmaz U., Zengin N., Buyukunal E., et al.
ONCOLOGY
, cilt.85, sa.6, ss.328-335, 2013 (SCI-Expanded, Scopus)
2013
20136. Male breast cancers behave differently in elderly patients
Tural D., Selcukbiricik F., Aydogan F., Bese N., Yetmen O., Ilvan Ş., et al.
Japanese Journal of Clinical Oncology
, cilt.43, sa.1, ss.22-27, 2013 (SCI-Expanded, Scopus)
2012
20127. A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients
Tural D., Selcukbiricik F., Serdengecti S., Buyukunal E.
WORLD JOURNAL OF SURGICAL ONCOLOGY
, cilt.10, 2012 (SCI-Expanded, Scopus)
2010
20108. Mide karsinomlarında postoperatif kemoradyoterapi tedavi sonuçları: Cerrahpaşa deneyimi
ÇOLPAN ÖKSÜZ D., Eren M. F., BEŞE F. N., BÜYÜKÜNAL E., ÖZGÜROĞLU M., Mandel N. M., et al.
TÜRK ONKOLOJİ DERGİSİ , sa.25, ss.1-10, 2010 (Scopus)
2007
20079. Paraneoplastic pemphigus associated with fludarabine use
Yıldız O., Özgüroğlu M., Yanmaz M. R., Turna H., Kursunoglu S. G., Antonov M., et al.
Medical Oncology
, cilt.24, sa.1, ss.115-118, 2007 (SCI-Expanded, Scopus)
2005
200510. Toxicity and survival results of a phase II study investigating the role of postoperative chemoradioimmunotherapy for gastric adenocarcinoma
Bese N., Buyukunal E., Ozguroglu M., Demir G., Yildirim A., Mandel N. K., et al.
STRAHLENTHERAPIE UND ONKOLOGIE
, cilt.181, sa.10, ss.652-659, 2005 (SCI-Expanded, Scopus)
2004
200411. Mismanagement of cancer pain: Attitudes of physicians and perception of pain and its treatment by the cancer patients
Serdengecti S., Ozguroglu M., Toptas T., Velet M., Yanmaz T., Buyukunal E.
ANNALS OF ONCOLOGY
, cilt.15, ss.211-212, 2004 (SCI-Expanded, Scopus)
2000
200012. Serum erythropoietin level in anemic cancer patients
Ozguroglu M., Arun B., Demir G., Demirelli F. H., Mandell N., Buyukunal E., et al.
MEDICAL ONCOLOGY
, cilt.17, sa.1, ss.29-34, 2000 (SCI-Expanded, Scopus)
1999
199913. Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma
Ozguroglu M., Turna H., Demir G., Doventas A., Demirelli F. H., Mandel N. K., et al.
American Journal of Clinical Oncology: Cancer Clinical Trials
, cilt.22, sa.6, ss.615-618, 1999 (SCI-Expanded, Scopus)
1999
199914. Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma - Mimicking metastatic tumor on abdominal CT
Ozguroglu M., Celik A. F., Demir G., Aki H., Demirelli F. H., Mandel N. K., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.29, sa.1, ss.96-98, 1999 (SCI-Expanded, Scopus)
1999
199915. Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study)
Demir G., Ozguroglu M., Sayhan N., Molinas-Mandel N., Demirelli F. H., Buyukunal E., et al.
ANTICANCER RESEARCH
, cilt.19, ss.3517-3520, 1999 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2012
20121. Thromboembolic complications in cancer patients.
Yenidunya G., Turna H., Ozturk M. A., Tural D., Selcukbiricik F., Yildiz O., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
20122. Bevacizumab (BEV) plus capecitabine as maintenance therapy after initial treatment with BEV plus XELOX in previously untreated patients (pts) with metastatic colorectal cancer (mCRC): Mature data from STOP and GO, a phase III, randomized, multicenter study
Yalcin S., Uslu R., Dane F., Yilmaz U., Zengin N., Buyukunal E., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
20123. NOD POZİTİF MEME KANSERLERİNDE PRİMER TÜMÖR VE AKSİLLER METASTAZIN ER, PR VE HER2 EKSPRESYONU AÇISINDAN KARŞILAŞTIRILMASI
ÖZTÜRK M. A., AYDIN Ö., İLVAN Ş., TURNA Z. H., TURAL D., YILDIZ Ö., et al.
4. TIBBİ ONKOLOJİ KONGRESİ, Antalya, Türkiye, 21 - 25 Mart 2012, ss.103, (Özet Bildiri)
2006
20064. Imatinib mesylate response in Gastrointestinal Stromal Tumors: Experience of cerrahpasa medical faculty
Yildiz I., Mandel N. M., Demir G., Ozguroglu M., Toptas T., Buyukunal E., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.164, (Özet Bildiri)
2006
20065. Trastuzumab beyond progression in metastatic breast cancer
Yanmaz M. T., Ozguroglu M., Ozturk B., Uygun K., Basaran G., Turna H., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.77, (Özet Bildiri)